Holen Sie sich die Stockscreener-App
0.63
6.74%
0.0398
Schlusskurs vom Vortag:
$0.5902
Offen:
$0.619
24-Stunden-Volumen:
77,653
Relative Volume:
0.11
Marktkapitalisierung:
$24.53M
Einnahmen:
$20.35M
Nettoeinkommen (Verlust:
$-59.43M
KGV:
-0.6117
EPS:
-1.03
Netto-Cashflow:
$-30.96M
1W Leistung:
-3.86%
1M Leistung:
-9.47%
6M Leistung:
-38.83%
1J Leistung:
-52.63%
1-Tages-Spanne:
$0.6151
$0.6474
1-Wochen-Bereich:
$0.5684
$0.6677
52-Wochen-Spanne:
$0.56
$1.9298
Dariohealth Corp Stock (DRIO) Company Profile
Firmenname
Dariohealth Corp
Sektor
Branche
Telefon
972-4-770-6377
Adresse
322 W 57TH ST. #33B, NEW YORK
Vergleichen Sie DRIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
0.638 | 24.53M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
226.83 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.93 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
49.60 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.54 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.15 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2022-05-13 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2021-04-22 | Eingeleitet | Cowen | Outperform |
| 2021-03-23 | Eingeleitet | Stifel | Buy |
| 2021-02-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-01 | Herabstufung | Alliance Global Partners | Buy → Neutral |
| 2020-08-17 | Eingeleitet | Aegis Capital | Buy |
| 2017-08-29 | Eingeleitet | Aegis Capital | Buy |
| 2016-05-09 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Dariohealth Corp Aktie (DRIO) Neueste Nachrichten
DarioHealth (NASDAQ:DRIO) Stock Passes Below 200-Day Moving Average – Here’s Why - Defense World
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know - MSN
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth - Sharewise
C O R R E C T I O N -- DarioHealth Corp./ -February 06, 2025 at 08:30 am EST - Marketscreener.com
DarioHealth granted extension to regain Nasdaq compliance By Investing.com - Investing.com South Africa
DarioHealth (DRIO) to Release Earnings on Thursday - Defense World
DarioHealth granted extension to regain Nasdaq compliance - Investing.com
DarioHealth (NASDAQ:DRIO) Stock Price Crosses Below 200 Day Moving Average – Here’s Why - Defense World
DarioHealth Reports Strong Revenue Growth in 2024 - TipRanks
DarioHealth Announces New Agreement with a Large Regional Health Plan - Longview News-Journal
DarioHealth Appoints New Auditing Firm PwC Member - TipRanks
DarioHealth (NASDAQ:DRIO) Price Target Lowered to $2.00 at Stifel Nicolaus - Defense World
DarioHealth’s Earnings Call Highlights Robust Growth - TipRanks
Stifel cuts DarioHealth stock target to $2, maintains buy rating - Investing.com
Stifel cuts DarioHealth stock target to $2, maintains buy rating By Investing.com - Investing.com South Africa
DarioHealth Corp. (NASDAQ:DRIO) Q4 2024 Earnings Call Transcript - Insider Monkey
DarioHealth revenue increases 32.9% to USD 27M in 2024 - Medical Buyer
DarioHealth’s Balanced Outlook: Promising Growth Amidst Uncertainties Justifies Hold Rating - TipRanks
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue - sharewise
Earnings call transcript: DarioHealth Q4 2024 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: DarioHealth Q4 2024 beats EPS expectations - Investing.com India
DarioHealth Corp reports results for the quarter ended December 31Earnings Summary - TradingView
DarioHealth earnings beat by $0.15, revenue topped estimates - Investing.com
DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results - GuruFocus.com
DARIOHEALTH Earnings Results: $DRIO Reports Quarterly Earnings - Nasdaq
DarioHealth Expects To Realize Additional 20% Reduction In Operating Expenses Between Q4 2025 & Q4 2025 - Marketscreener.com
DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025 - Marketscreener.com
DarioHealth Corp. SEC 10-K Report - TradingView
DarioHealth Corp. to Host Earnings Call - ACCESS Newswire
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula - GuruFocus.com
DarioHealth (DRIO) Expected to Announce Earnings on Monday - Defense World
DarioHealth adds major healthcare system to client roster By Investing.com - Investing.com South Africa
DarioHealth adds major healthcare system to client roster - Investing.com
Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth - PR Newswire
DarioHealth expands board with healthcare veteran Larry Leisure By Investing.com - Investing.com Australia
Finanzdaten der Dariohealth Corp-Aktie (DRIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dariohealth Corp-Aktie (DRIO) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nelson Steven Charles | Chief Commercial Officer |
Sep 10 '24 |
Buy |
0.84 |
5,000 |
4,221 |
45,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 11 '24 |
Buy |
0.80 |
5,000 |
4,022 |
50,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 06 '24 |
Buy |
0.84 |
5,000 |
4,200 |
35,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 05 '24 |
Buy |
0.82 |
5,000 |
4,091 |
30,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Sep 09 '24 |
Buy |
0.80 |
5,000 |
4,000 |
40,000 |
| Raphael Erez | Chief Executive Officer |
Aug 27 '24 |
Buy |
0.88 |
5,000 |
4,400 |
1,937,059 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 23 '24 |
Buy |
0.95 |
5,000 |
4,750 |
25,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 22 '24 |
Buy |
0.94 |
5,000 |
4,725 |
20,000 |
| Nelson Steven Charles | Chief Commercial Officer |
Aug 21 '24 |
Buy |
0.93 |
5,000 |
4,672 |
15,000 |
| Raphael Erez | Chief Executive Officer |
Aug 21 '24 |
Buy |
0.95 |
5,000 |
4,750 |
1,932,059 |
0.20%
3.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):